Report : North America Gynecology Devices Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product (Surgical Devices, Hand Instruments, and Diagnostic Imaging System) and End User (Hospitals, Diagnostic Centers, Clinics, and Others)

At 10.6% CAGR, the North America Gynecology Devices Market is speculated to be worth US$ 9,312.31 million by 2028, says Business Market Insights         

According to Business Market Insights’ research, the North America gynecology devices market was valued at US$ 5,088.51 million in 2022 and is expected to reach US$ 9,312.31 million by 2028, registering an annual growth rate of 10.6% from 2022 to 2028. Rise in the incidences of gynecological diseases and increasing number of advanced medical devices for women are the critical factors attributed to the market expansion.                 

The health care industry is offering various technologically advanced products for the diagnosis and treatment of the gynecological problems of women. The advancement in the healthcare industry, specifically in the medical devices industry, has encouraged players to provide the best equipment, devices, and systems to their customers. Manufacturers of medical devices have devised innovative gynecological devices with better efficacy and reduced the patient’s discomfort by offering quick recovery. Moreover, the evolution of endometrial ablation devices for the treatment of menorrhagia and the usage of endoscopes in gynecological surgeries are a few of the prime developments in the gynecology devices market in the last few years. For instance, in 2018, General Electric Company launched Versana Essential, a new ultrasound system having a wide range of medical applications and has Whizz one-touch dynamic image optimization features. Further, the company launched LOGIQ E10, a new generation of high-end radiology ultrasound systems that is the most technologically-advanced ultrasound that offers fast, precise, consistent imaging of the patients. The advancement in the system has enabled minimal invasive gynecological surgeries. For instance, Cooper Surgical offers a vast range of minimally invasive products for gynecological services. Hologic, Inc. provides minimally invasive treatment options that use science and technology to restore the quality of life for women facing gynecological conditions. Therefore, the availability of various gynecology devices that aid in increasing the efficiency of minimally invasive procedures and the development of imaging devices, such as 3D endoscopes, is driving the gynecology devices market.

On the contrary, limited access to contraception hurdles the growth of North America gynecology devices market.

Based on product, the North America gynecology devices market is segmented into surgical devices, hand instruments, and diagnostic imaging system. The surgical devices segment held 54.2% market share in 2022, amassing US$ 2,759.30 million. It is projected to garner US$ 5,156.76 million by 2028 to expand at 11.0% CAGR during 2022–2028.  

Based on end user, the North America gynecology devices market is segmented into hospitals, diagnostic centers, clinics, and others. The hospitals segment held 48.6% market share in 2022, amassing US$ 2,470.53 million. It is projected to garner US$ 4,586.61 million by 2028 to expand at 10.9% CAGR during 2022–2028.  

Based on country, the North America gynecology devices market has been categorised into the US, Canada, and Mexico.  Our regional analysis states that the US captured 88.4% market share in 2022. It was assessed at US$ 4,497.97 million in 2022 and is likely to hit US$ 8,281.10 million by 2028, exhibiting a CAGR of 10.7% during the forecast period.    

Key players dominating the North America gynecology devices market are Boston Scientific Corporation; CooperSurgical, Inc; Ethicon; General Electric Company; Hologic, Inc.; KARL STORZ SE & Co. KG; Medtronic; Olympus Corporation; Richard Wolf GmbH.; and Stryker among others.   


  • In Feb 2022, Stryker, one of the world’s leading medical technology companies, will debut the new PROstep MICA SOLO Guide. The all-in-one procedure guide is used during PROstep MICA minimally invasive bunion procedures and is designed for use by a solo surgeon, potentially eliminating the need for additional surgical assistance during the operation.  


  • In Sep 2020, GE Healthcare Unveils Voluson SWIFT, AI-Enhanced Women’s Health Ultrasound with Industry-First Auto Recognition Tools to Help Improve Efficiency. Voluson SWIFT redefines the ultrasound experience for women’s health practitioners by integrating intelligent features that can reduce patient scanning time by as much as 45 percent and automate exam measurements resulting in significant time savings for users.

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id:

Download Free PDF Brochure